Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 5, 2005, Pages 352-360

  Cherki, Mounia ^a   Derouiche, Abdelfettah ^a   Drissi, Anas ^a   El Messal, Mariame ^b   Bamou, Youssef ^c   Idrissi Ouadghiri, Azzedine ^c   Khalil, Abdelouahed ^d   Adlouni, Ahmed ^a  

^a FACULTÉ DES SCIENCES BEN M SIK   (Morocco)

^b FACULTÉ DES SCIENCES AIN CHOCK   (Morocco)

^c Military Hospital Moulay Ismail   (Morocco)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Argan oil; Interventional study; Olive oil; Oxidation; PON1

Indexed keywords

EID: 27644462581     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2004.08.005     Document Type: Article

References (41)

1. Steinberg D, Lewis A. Conner memorial lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-71.
2. Esterbauer H, Striegl G, Puhl H, Puhl H, Oberreither S, Rotheneder M, et al. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann N Y Acad Sci 1989;570:254-67.
3. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb Vasc Biol 1993;13:590-600.
4. Mackness MI, Abbott CA, Arrol S. The role of high-density lipoprotein and lipid soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation. Biochem J 1993;294:829-34.
5. Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871-9.
6. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999;19:330-5.
7. Jaouad L, Milochevitch C, Khalil A. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic Res 2003;37:77-83.
8. Voetsch B, Benke KS, Damasceno BP, Siqueira LH, Loscalzo J. Paraoxonase 192 Gln → Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 2002;33:1459-64.
9. Mackness M, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003;107:2775-9.
10. Tomas M, Senti M, Elosua R, Vila J, Sala J, Masia R, et al. Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. Eur J Pharmacol 2001;432:121-8.
11. de Roos NM, Schouten EG, Scheek LM, van Tol A, Katan MB. Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metabolism 2002;51:1534-7.
12. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002;22:1329-33.
13. Khallouki F, Younos C, Soulimani R, Oster T, Charrouf Z, Spiegelhalder B, et al. Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocopherols, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur J Cancer Prev 2003;12:67-75.
14. Drissi A, Girona J, Cherki M, Godàs G, Derouiche A, El Messal M, et al. Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa). Clin Nutr 2004;23:1159-66.
15. Répertoire général des aliments: Technique et documentation. Lavoisier-INRA-Ciquel-Régal, Paris, ed; 1991.
16. Boukhobza M, Pichon-Prun N. L'arganier ressource économique et médicinale pour le Maroc. Phytothérapie 1988;27:21-6.
17. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol 1994;233:469-89.
18. Gan K, Smolen A, Eckerson H, La Du N. Purification of human serum paraoxonase/arylesterase, evidence for one esterase catalysing both activities. Drug Metab Dispos 1990;19:100-6.
19. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126-38.
20. Khalil A, Fortin JP, LeHoux JG, Fulop T. Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation. J Lipid Res 2000;41:1552-61.
21. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627-30.
22. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demacker PNM. Improved measurement of low-density lipoprotein susceptibility to copper induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992;38:2066-72.
23. Berrada Y, Settaf A, Baddouri K, Cherrah Y, Hassar M. Mise en évidence expérimentale des effets antihypertenseurs et hypocholesterolémiants de l'huile d'argan, Argania sideroxylon. Thérapie 2000;55:375-8.
24. Berrougui H, Ettaib A, Herrera Gonzalez MD, Alvarez de Sotomayor M, Bennani-Kabchi A, Hmamouchi M. Hypolipidemic and hypocholesterolemic effect of argan oil (Argania spinosa L.) in Meriones shawi rats. J Ethnopharmacol 2003;89:15-8.
25. Masella R, Giovannini C, Vari R, Di Benedetto R, Coni E, Volpe R. Effect of dietary virgin olive oil phenols on low density lipoprotein oxidation in hyperlipidemic patients. Lipids 2001;36:1195-202.
26. Fuhram B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
27. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation a dose-response study. Arterioscler Thromb Vasc Biol 1995;15:190-8.
28. Gimeno E, Fito M, Lamuela-Raventos RM, Castellote AI, Covas M, Farre M, et al. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur J Clin Nutr 2002;56:114-20.
29. Visioli F, Bellomo G, Montedoro G, Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 1995;117:25-32.
30. Wiseman SA, Mathot JN, de Fouw NJ, Tijburg LB. Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits. Atherosclerosis 1996;120:15-23.
31. Zieden B, Kaminskas A, Kristenson M, Olsson AG, Kucinskiene Z. Long chain polyunsaturated fatty acids may account for higher low-density lipoprotein oxidation susceptibility in Lithuanian compared to Swedish men. Scand J Clin Lab Invest 2002;62:307-14.
32. Elmadfa I, Kim SW, Reutlinger M, Siewert R. The transformation of gamma-tocopherol to alpha-tocopherol in the animal organism: a generational study in rats. Z Ernahrungswiss 1989;28:36-48.
33. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68:258-65.
34. Berra B, Caruso D, Cortesi N, Fedeli E, Rasetti M, Galli G. Antioxidant properties of minor polar components of olive oil on oxidative processes of cholesterol in human LDL. Riv Ital Sost Grasse 1995;72:285-8.
35. Watson AD, Berliner JA, Hama SY. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882-91.
36. Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, Mutanen M. Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis 2002;160:425-32.
37. Hedrick C, Hassan K, Hough G, Yoo J, Simzar S, Quinto C, et al. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Arterioscler Thromb Vasc Biol 2000;20:1946-52.
38. Mackness M, Mackness B, Durrington P, Connelly P, Hegele R. Paraoxonase: biochemistry, genetics and relationship to serum lipoproteins. Curr Opin Lipidol 1996;7:69-76.
39. Sutherland W, Walker R, de Jong S, van Rij A, Phillips V, Walker H. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 1999;19:1340-7.
40. Wallace AJ, Sutherland WH, Mann JI, Williams SM. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur J Clin Nutr 2001;55:951-8.
41. Nguyen SD, Sok DE. Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochem J 2003;375:275-85.